Kaneko M, Mashiko H, Yagiuchi T, Ohsuka N, Kumashiro H
Department of Neuropsychiatry, Fukushima Medical College, Japan.
Jpn J Psychiatry Neurol. 1992 Mar;46(1):169-74. doi: 10.1111/j.1440-1819.1992.tb00830.x.
The 5HT-induced shape change (5HT-SC) of blood platelets, which had been suggested to reflect the 5HT2 receptor-mediated function of the central nervous system (CNS), was examined in patients with depression before or after antidepressant therapy. The degree of 5HT-SC did not differ between patients before treatment (n = 17) and healthy controls (n = 26). In patients after treatment (n = 12), in whom depression had been improved but drug therapy was continued, 5HT-SC in a concentration of 10(-5) M 5HT was observed more potently than that in healthy controls or untreated patients (p less than 0.05 and p less than 0.05, respectively). In 4 patients in whom 5HT-SC was measured before and after mianserin treatment, 5HT-SC increased after the treatment. These results suggest that the 5HT2 receptor-mediated function in the CNS may not be damaged in patients with depression, and that the 5HT2 receptor-mediated function in the CNS may be enhanced by antidepressants.
血小板的5-羟色胺诱导的形态变化(5HT-SC)被认为反映了中枢神经系统(CNS)的5HT2受体介导的功能,本研究在抑郁症患者抗抑郁治疗前后对其进行了检测。治疗前患者(n = 17)与健康对照者(n = 26)之间的5HT-SC程度无差异。在治疗后患者(n = 12)中,抑郁症已有所改善但仍继续药物治疗,观察到10(-5)M 5HT浓度下的5HT-SC比健康对照者或未治疗患者更显著(分别为p < 0.05和p < 0.05)。在4例米安色林治疗前后测量5HT-SC的患者中,治疗后5HT-SC增加。这些结果表明,抑郁症患者中枢神经系统中5HT2受体介导的功能可能未受损,并且抗抑郁药可能增强中枢神经系统中5HT2受体介导的功能。